TB-500 (Thymosin Beta 4)

TB500 research peptide primarily sequesters G-actin, maintaining a pool of monomeric actin that facilitates rapid polymerization into F-actin filaments, thereby supporting cell motility, shape maintenance, and migration essential for repair processes. Furthermore, it promotes angiogenesis through upregulation of VEGF and related pathways, stimulates endothelial cell proliferation and tube formation, while modulating anti-inflammatory responses by inhibiting NF-κB activation and reducing pro-inflammatory cytokine release. Additionally, laboratory models reveal decreased apoptosis via enhanced BCL-2 expression, reduced caspase activity, and protection against oxidative stress, alongside accelerated collagen deposition and decreased myofibroblast activity to minimize fibrosis. These multifaceted actions, observed in rodent wound, cardiac, and neural injury models, contribute to observed improvements in tissue remodeling and functional recovery, with recent research emphasizing its reassuring potential for balanced regenerative signaling in various injury contexts.

• Actin dynamics and cell migration investigations

• Angiogenesis and VEGF pathway mechanism analysis

• Wound healing and epithelialization studies

• Anti-inflammatory and anti-apoptotic pathway research

• Tissue regeneration and fibrosis reduction evaluations

• Neuroprotection and musculoskeletal repair examinations

• Goldstein AL et al. Ann N Y Acad Sci. 2007;1112:1-13
• Sosne G et al. Ann N Y Acad Sci. 2010;1194:81-86
• Philp D et al. Expert Opin Biol Ther. 2007;7(6):843-854
• Crockford D et al. Ann N Y Acad Sci. 2010;1194:179-189
• Malinda KM et al. FASEB J. 1997;11(6):474-481